Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States. (Q46350021)
Jump to navigation
Jump to search
scientific article published on 29 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States. |
scientific article published on 29 January 2013 |
Statements
Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States (English)
David W Hutton
Curtis D Collins
29 January 2013